Cancer continues to be one of the leading causes of death worldwide. By 2040, the number of new cancer cases is expected to reach nearly 30 million. With rapid advances in science and technology, invasive methods for diagnosing and surveilling cancers are being supplanted by innovative, non-invasive methods like liquid biopsy. How might these technologies disrupt current practices? This panel of experts will offer a look into the innovations on the horizon and a prediction of how these innovations will affect the future of cancer care.